Primary graft function, metabolic control, and graft survival after islet transplantation

Diabetes Care

Volumn 32, Issue 8, 2009, Pages 1473-1478

  Vantyghem, Marie Christine ^a,b,c   Kerr Conte, Julie ^a,b,d   Arnalsteen, Laurent ^a,b,c   Sergent, Geraldine ^c   Defrance, Frederique ^a,b,c   Gmyr, Valery ^a,b,d   Declerck, Nicole ^c   Raverdy, Violeta ^a,b,c   Vandewalle, Brigitte ^a,b   Pigny, Pascal ^a,c   Noel, Christian ^a,c   Pattou, Francois ^a,b,c,d  

^a UNIV LILLE   (France)

^b INSERM   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d IMPRT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; DACLIZUMAB; GLUCOSE; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A1C; HEPARIN; HLA ANTIBODY; INSULIN; PANCREAS ISLET CELL ANTIBODY; PANEL REACTIVE ANTIBODY; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS;

ADULT; ANEMIA; ARTHRALGIA; ARTICLE; BILE LEAKAGE; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE OBSTRUCTION; INTRAVENOUS ADMINISTRATION; MALE; MICROALBUMINURIA; NEUTROPENIA; PANCREAS ISLET TRANSPLANTATION; PRIMARY GRAFT FUNCTION; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; PORTAL VEIN; TACROLIMUS; TREATMENT OUTCOME;

EID: 68149137067     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1685     Document Type: Article

References (25)

1. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355: 1318-1330 (Pubitemid 44465460)
2. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. Five-year follow-up after clinical islet transplantation. Diabetes 2005;54: 2060-2069 (Pubitemid 40911269)
3. Froud T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure P, Pileggi A, Poggioli R, Ichii H, Khan A, Ferreira JV, Pugliese A, Esquenazi VV, Kenyon NS, Alejandro R. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005;5:2037-2046 (Pubitemid 41039883)
4. Gerber PA, Pavlicek V, Demartines N, Zuellig R, Pfammatter T, Wuthrich R, Weber M, Spinas GA, Lehmann R. Simultaneous islet-kidney vs pancreas-kidney transplantation in type 1 diabetes mellitus: a 5 year single centre follow-up. Diabetologia 2008;51:110-119 (Pubitemid 50000367)
5. Collaborative Islet Transplantation Registry. Annual Report. Rockville, Maryland, The EMMES Corporation, 2007
6. Bertuzzi F, Ricordi C. Prediction of clinical outcome in islet allotransplantation. Diabetes Care 2007;30:410-417 (Pubitemid 46201652)
7. Larsen JL. Pancreas transplantation: indications and consequences. Endocr Rev 2004;25:919-946
8. Hubert T, Strecker G, Gmyr V, Arnalsteen L, Garrigue D, Ezzouaoui R, Caiazzo R, Dezfoulian G, Averland B, Vandewalle B, Vantyghem MC, Kerr-Conte J, Pattou F. Acute insulin response to arginine in deceased donors predicts the outcome of human islet isolation. Am J Transplant 2008;8:872-876 (Pubitemid 351347745)
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 2007; 30(Suppl. 1):S42-S47
10. Ryan EA, Paty BW, Senior PA, Lakey JR, Bigam D, Shapiro AM. β-Score: an assessment of β-cell function after islet transplantation. Diabetes Care 2005;28:343-347 (Pubitemid 40170937)
11. Caumo A, Maffi P, Nano R, Bertuzzi F, Luzi L, Secchi A, Bonifacio E, Piemonti L. Transplant estimated function: a simple index to evaluate β-cell secretion after islet transplantation. Diabetes Care 2008; 31:301-305 (Pubitemid 351213340)
12. Kilpatrick ES, Rigby AS, Atkin SL. Mean blood glucose compared with HbA(1c) in the prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia 2008;51:365-371
13. Rickels MR, Kamoun M, Kearns J, Markmann JF, Naji A. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. J Clin Endocrinol Metab 2007;92:2410-2414 (Pubitemid 47037334)
14. The Worcester Human Islet Transplantation Group. Autoimmunity after islet-cell allotransplantation. N Engl J Med 2006; 355:1397-1399
15. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333:333-336
16. Terasaki PI, Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial. Transplantation 2005;80: 1194-1197 (Pubitemid 41746796)
17. Szoke E, Shrayyef MZ, Messing S, Woerle HJ, van Haeften TW, Meyer C, Mitrakou A, Pimenta W, Gerich JE. Effect of aging on glucose homeostasis: accelerated deterioration of β-cell function in individuals with impaired glucose tolerance. Diabetes Care 2008;31:539-543
18. Davalli AM, Maffi P, Socci C, Sanvito F, Freschi M, Bertuzzi F, Falqui L, Di Carlo V, Pozza G, Secchi A. Insights from a successful case of intrahepatic islet transplantation into a type 1 diabetic patient. J Clin Endocrinol Metab 2000;85:3847-3852 (Pubitemid 30828600)
19. Smith RN, Kent SC, Nagle J, Selig M, Iafrate AJ, Najafian N, Hafler DA, Auchincloss H, Orban T, Cagliero E. Pathology of an islet transplant 2 years after transplantation: evidence for a nonimmunological loss. Transplantation 2008;86: 54-62
20. Vantyghem MC, Marcelli-Tourvieille S, Fermon C, Duhamel A, Raverdy V, Arnalsteen L, Kerr-Conte J, Noel C, Fontaine P, Pattou F. Intraperitoneal insulin infusion versus islet transplantation: comparative study in patients with type 1 diabetes. Transplantation 2009;87:66-71
21. Fung MA, Warnock GL, Ao Z, Keown P, Meloche M, Shapiro RJ, Ho S, Worsley D, Meneilly GS, Al Ghofaili K, Kozak SE, Tong SO, Trinh M, Blackburn L, Kozak RM, Fensom BA, Thompson DM. The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report. Transplantation 2007;84: 17-22 (Pubitemid 47094636)
22. Maffi P, Bertuzzi F, De Taddeo F, Magistretti P, Nano R, Fiorina P, Caumo A, Pozzi P, Socci C, Venturini M, del Maschio A, Secchi A. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy. Diabetes Care 2007;30:1150-1155 (Pubitemid 46684640)
23. Keymeulen B, Gillard P, Mathieu C, Movahedi B, Maleux G, Delvaux G, Ysebaert D, Roep B, Vandemeulebroucke E, Marichal M, In 't Veld P, Bogdani M, Hendrieckx C, Gorus F, Ling Z, van Rood J, Pipeleers D. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci U S A 2006;103:17444-17449
24. Caiazzo R, Gmyr V, Kremer B, Hubert T, Soudan B, Lukowiak B, Vandewalle B, Vantyghem MC, Pattou F, Kerr-Conte J. Quantitative in vivo islet potency assay in normoglycemic nude mice correlates with primary graft function after clinical transplantation. Transplantation 2008;86: 360-363
25. Eich T, Eriksson O, Lundgren T. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 2007; 356:2754-2755 (Pubitemid 47001066)